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Background: COVID-19 is a global challenge to healthcare. Obesity is common in
patients with COVID-19 and seems to aggravate disease prognosis. In this review we
explore the link between obesity, chronic disease, lifestyle factors and the immune
system, and propose societal interventions to enhance global immunity.
Search Strategy and Selection Criteria: We performed three literature searches using
the keywords (1) coronavirus AND comorbidities, (2) comorbidities AND immune system,
and (3) lifestyle factors AND immune system. Results were screened for relevance by the
main author and a total of 215 articles were thoroughly analyzed.
Results: The relationship between obesity and unfavorable COVID-19 prognosis is
discussed in light of the impact of chronic disease and lifestyle on the immune system.
Several modifiable lifestyle factors render us susceptible to viral infections. In this context,
we make a case for fostering a healthy lifestyle on a global scale.
Conclusions: Obesity, additional chronic disease and an unhealthy lifestyle interactively
impair immune function and increase the risk of severe infectious disease. In adverse
metabolic and endocrine conditions, the immune system is geared toward inflammation.
Collective effort is needed to ameliorate modifiable risk factors for obesity and chronic
disease on a global scale and increase resistance to viruses like SARS-CoV-2.
Keywords: obesity, diet, COVID-19, lifestyle, immune system
INTRODUCTION
In recent months the entire globe has been affected by coronavirus disease 2019 (COVID-19),
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Worldwide more
than 11 million cases of COVID-19 have been detected until July 2020 and over 500,000
cases have proved fatal (2) Despite serious efforts, no effective vaccine has been developed yet.
But, even without a vaccine, the impact of subsequent waves of SARS-CoV-2 spreading can
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most likely be decreased. Among patients with COVID-19,
obesity, hypertension, cardiovascular disease (CVD) and type
2 diabetes (T2D) are noticeable risk factors for hospitalization,
ICU admission, and death. Apparently, chronic disease is linked
with unfavorable outcome in COVID-19. As appropriate lifestyle
intervention effectively ameliorates cardiometabolic conditions,
public health could play a pivotal role in the battle against
SARS-CoV-2 (3). The aim of this review is to summarize the
current understanding of the links between lifestyle, metabolic
syndrome, obesity, and increased susceptibility to viral infections.
In addition, we aim to investigate whether public health
interventions can affect resistance to viral infections.
SEARCH STRATEGY AND SELECTION
CRITERIA
Three separate literature searches were performed in
PubMed, EMBASE, and Google Scholar through April
2020 to May 2020. We considered English-language
(systematic) review articles and meta-analyses found using
the following term combinations: (1) “Coronavirus” and
“diabetes/hypertension/obesity/cardiovascular disease/metabolic
syndrome” yielding 1,132 articles on April 29, 2020. (2) “Immune
system” and “diabetes/hypertension/obesity/cardiovascular
disease/metabolic syndrome” yielding 1,364 articles on May
17, 2020. (3) “Immune system” and “lifestyle” yielding 753
results on June 4, 2020. The complete search strategies can be
found in Supplementary Material. References lists of identified
publications were also screened for relevant studies. If multiple
articles were found per subject, preference went to clarity,
relevance, and novelty. A total of 215 articles (17, 151, and 47 for
search strategies 1, 2, and 3, respectively) were scrutinized for
this review.
OBESITY AND CARDIOMETABOLIC
DISEASES ARE RELATED TO WORSE
OUTCOME OF COVID-19
The Chinese Center for Disease Control reports higher COVID-
19 fatality rates in patients with comorbidities as compared with
patients without (4). The fatality rate for patients with COVID-19
without comorbidities was 0.9%, whereas fatality rates in patients
with diabetes (7.3%), CVD (10.5%), and hypertension (6.0%)
are clearly higher (4). American and European studies confirm
the higher chance of fatality and severe disease in patients with
comorbidities and add obesity as another risk factor. According
to the American Center for Disease Control and Prevention
obesity was present in 48.3% of the hospitalized patients with
laboratory-confirmed COVID-19 (5). It was also reported that
89.3% of patients with COVID-19 registered in COVID-NET
had other underlying conditions, most of them obesity-related:
hypertension (49.7%), chronic lung disease (34.6%), diabetes
mellitus (28.3%), and CVD (27.8%). Notably, among patients
aged 50–64 years, obesity was most prevalent, followed by
hypertension and diabetes mellitus. Among those aged >65
years, hypertension was most prevalent, followed by CVD and
diabetes mellitus (5).
TABLE 1 | Overview of mechanisms by which obesity contributes to worse
prognosis of COVID-19.
Immune system Chronic innate immune system activation
Adaptive immune system dysregulation
Lymphopenia
Endocrine and metabolic
dysregulation in adipose tissue
Increased leptin secretion (pro-inflammatory)
Decreased adiponectin secretion
(anti-inflammatory)
Hypoxia leading to low grade inflammation
Respiratory impairment Reduced compliance, increased resistance
Airway narrowing and collapse
Reduced functional residual capacity
Airway hyperresponsiveness
Ventilation perfusion mismatch
Hemostasis Enhanced prothrombotic state
Viral shedding ACE2 expression on adipocytes
Adipose tissue as potential reservoir for viruses
Comorbidities Metabolic syndrome
Type 2 Diabetes
Cardiovascular disease, including hypertension
Obstructive sleep apnea
Furthermore, a study of 4,103 positively tested patients with
COVID-19 in New York revealed more frequent hospitalization
of patients with obesity (39.8 vs. 14.5%), CVD (44.6 vs.
16.4%), and diabetes (31.8 vs. 5.4%) than in patients without
comorbidities (6).
THE RELATIONSHIP BETWEEN OBESITY
AND UNFAVORABLE OUTCOME OF
COVID-19
Obesity is evidently associated with COVID-19 in terms of
prevalence of symptomatic disease, disease severity andmortality
(7, 8). Individuals with obesity have an approximately 3-fold
increased risk of severe COVID-19 (7). Each unit increase
in BMI was associated with a 12% increase in the risk of
severe disease and obesity increased the need for invasive
mechanical ventilation (7, 8). Furthermore, in patients below
60 years of age, who are generally considered to have a lower
risk for severe disease, obesity appears to be a risk factor for
hospital admission and need for critical care (9). Interestingly,
similar associations were observed in other (viral) infections.
During the Influenza A (H1N1) pandemic of 2009–2011, obesity
was strongly associated with a worse disease outcome and
death (10). Obesity also increases the duration of Influenza A
virus shedding in adults, indicative of an impaired immune
response that subsequently facilitates influenza transmission
(11). Multiple mechanisms in obesity aggravate prognosis in
COVID-19 (Table 1). Below we discuss the most important
mechanisms known to date.
The Immune System
The immune system uses two sequential responses to react
to disturbances in homeostasis, as seen in tissues under
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physiological or infectious stress. An initial rapid innate immune
response, which has only broad specificity for the trigger is
followed by a delayed, highly specific adaptive immune response
(12). The latter generates long term target-specific immune
memory. Both types of responses require specialized white
blood cell types, such as granulocytes, macrophages, and natural
killer cells that are innate immune populations, while different
types of T- and B-lymphocytes constitute the adaptive immune
cells. Although often designated distinct immune responses
it should be realized that innate and adaptive responses are
highly interdependent.
In obesity, both local and systemic immune alterations
occur due to metabolic stress (13). In adipose tissue, the anti-
inflammatory/immune regulatory primed immune cells (e.g.,
M2-type macrophages, regulatory T cells (Treg), T-helper (Th)2,
type 2 innate lymphoid cells (ILC2) normally present in lean
adipose tissue are replaced by increased numbers of pro-
inflammatory primed immune cells (e.g., M1 macrophages, Th1,
Th17, CD8+ T-cells) that secrete pro-inflammatory cytokines
such as IL-1β, IL-6, IL-17, and IFN-γ. This may even be
further enhanced by obesity-associated gut inflammation (13).
In addition to local adipose tissue immune alterations, systemic
immune adaptations are observed in obesity as well, including
increased numbers of circulating (inflammatory) monocytes,
neutrophils, Th1, Th17, Th22, decreased circulating Treg and
elevated pro-inflammatory cytokine levels (14, 15). In concert,
these changes lead to a pro-inflammatory state of the immune
system in individuals with obesity, characterized by elevated
cytokine levels, both locally in the adipose tissue as well as
systemically, as depicted in Figure 1. This chronically elevated
inflammatory state is thought to stimulate regulatory pathways,
which in turn limit the response to an acute trigger such as
SARS-CoV-2. This is exemplified by the hampered antiviral type
I interferon response in individuals with obesity (16).
Besides systemic upregulation of pro-inflammatory cytokines,
severe COVID-19 is associated with lymphopenia and T cell
exhaustion (17). This may be related to functional depletion of
the antigen-presenting dendritic cells due to viral infection, since
they express both angiotensin-converting-enzyme 2 (ACE2) and
the alternative viral receptor DC-SIGN (18). Substantial T-
cell apoptotic death might then be caused by T-cell receptor
engagement in the absence of appropriate co-stimulation,
normally provided by dendritic cells. Moreover, SARS-CoV-2
hampers the function of CD4+ T cells and promotes excessive
activation and possibly subsequent exhaustion of CD8+ T cells.
Together, these perturbations of T cell subsets likely diminish
host antiviral immunity (19). Obesity further worsens this
condition as DC maturation appears to be hampered, which
in itself already impacts the elicitation of appropriate T-cell
responses (20).
Endocrine and Metabolic Dysregulation in
Adipose Tissue
Adipose tissue changes play an important role in obesity
associated chronic systemic inflammation. Changes in adipokine
secretion, fatty acid induced inflammation, oxidative stress,
endoplasmic reticulum (ER) stress, and adipose tissue hypoxia
are proposed mechanisms (21). Adipocytes secrete adipokines
such as leptin and adiponectin, that can modulate the immune
system (21, 22). In obesity, leptin secretion is increased. Leptin
is pro-inflammatory and stimulates monocyte proliferation
and differentiation into macrophages, modulates the activation
of natural killer cells, and induces the production of pro-
inflammatory cytokines such as TNFα, IL-6, or IL-12 (21).
However, leptin inhibits anti-viral type I interferons (16). At
the same time, the secretion of adiponectin, which has opposite
immunomodulatory effects, is diminished. Adiponectin inhibits
phagocytic activity and production of TNFα production, the
synthesis of adhesion molecules, the formation of foam cells and
stimulates the release of anti-inflammatory cytokines (e.g., IL-
10). Nutrient excess and cell expansion in obesity can induce ER
stress. ER stress is linked to the production of reactive oxygen
species and the activation of inflammatory pathways (21). In
addition, adipose tissue expansion in obesity eventually reaches
a point where the capacity of local vasculature is insufficient
leading to hypoxia. This hypoxic state aggravates the pro-
inflammatory profile through further upregulation of leptin,
downregulation of adiponectin, and increased production of
pro-inflammatory cytokines by resident macrophages (21).
Respiratory Impairment
Fat deposits in the mediastinum and abdominal cavity reduce
compliance of the lungs, chest wall, and entire respiratory
system. This likely contributes to respiratory symptoms of obesity
such as wheeze, dyspnea, and orthopnea (23). The mechanical
effects of obesity produce airway narrowing and closure,
increased respiratory system resistance, reduced functional
residual capacity, airway hyperresponsiveness, and a ventilation
perfusion mismatch, all of which decrease lung function (23).
Thus, altered lung function due to mechanical stress probably
contributes to the worse prognosis in patients with obesity
and COVID-19.
Hemostasis
Obesity is independently associated with both arterial and venous
thrombotic events (24). Related mechanisms are increased levels
of clotting factors (tissue factor, Factor VII, Factor VIII, and
plasminogen activator inhibitor) inflammation and endothelial
dysfunction (24). COVID-19 in its severe form is also associated
with both serious systemic inflammation and a prothrombotic
state, as reflected by a significant increase in fibrinogen and D-
dimer levels and high rates of severe pulmonary embolism that
forecast a poor prognosis (25). This could constitute another
link between obesity and worse outcome in COVID-19 but more
research is required to confirm this notion.
ACE2 Receptor, Viral Reservoir and
Lymphopenia
Other potential mechanisms through which obesity may lead to
worse COVID-19 prognosis are high ACE2 receptor expression
and comorbidities. Expression of ACE2—the functional receptor
for SARS-CoV-2 and other corona viruses—is upregulated in
adipocytes of patients with obesity and diabetes, which turns
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FIGURE 1 | Schematic overview of factors contributing to obesity and/or impairing weight loss. Next to obesity, most of these factors are also directly related to
alterations in the immune system leading to a pro-inflammatory state and subsequent comorbidities.
adipose tissue into a potential target and viral reservoir (11).
Potentially, this could result in prolonged viral shedding by
adipose tissue, with extended activation of local “preactivated”
immune responses and resident cytokine signaling pathways.
However, currently, there is no evidence yet for direct
SARS-CoV-2 infection of adipose tissue.
Comorbidities
Comorbidities associated with obesity have become major
health problems in patients that have been admitted to the
hospital (8). Below, we discuss the influence of metabolic
syndrome, T2D, CVD, and obstructive sleep apnea (OSA)
on the immune system. Obesity associated insulin resistance
drives the metabolic syndrome, a condition characterized by a
clustering of three or more of the following: central adiposity,
elevated blood glucose, elevated plasma triglycerides, elevated
blood pressure, and low plasma high density lipoprotein (26).
Components of the metabolic syndrome are associated with
low-grade chronic inflammation. In metabolic syndrome, levels
of leptin are increased aggravating leptin resistance enhancing
chronic inflammation. Also, circulating adiponectin levels are
decreased in metabolic syndrome, which impairs the resolution
of inflammation. In itself, metabolic syndrome increases the risk
of T2D and CVD by 2- and 5-fold, respectively (26).
The presence of T2D aggravates the prognosis in patients with
COVID-19 (27, 28). It is associated with an approximately 2-fold
increase of severe/critical COVID-19 illness, after adjustment for
age, sex, obesity, hypertension, and smoking (28). Also, higher
ICU admission rates and mortality risk were reported in patients
with diabetes and COVID-19 (29). The hazard ratio of death
was 1.53 in patients with diabetes after adjustment for age, sex,
hypertension, CVD, and cerebrovascular disease (27). Notably,
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SARS-CoV-1-, MERS-, and influenza-infections are also marked
by more severe symptoms in people with diabetes (27). Metabolic
disruption, low grade systemic inflammation, and an unbalanced
immune response may explain the more serious disease course
of infections in T2D (28). This is further discussed in the
Diet section.
CVD is a common comorbidity in COVID-19 (5). We did
not find any literature that specifically explored the relationship
between CVD and the capacity to respond to infectious
challenges. Also, hypertension is often reported as a highly
frequent comorbidity in severely ill patients with COVID-19
(5). Studies reveal higher ICU admission rates and higher
mortality rates in patients with COVID-19 with hypertension
(30). However, these data should be interpreted with caution as
age and CVDmay be important confounders (31). To date, there
is no conclusive evidence for an independent causal link between
hypertension and increased susceptibility for infectious diseases.
Nonetheless, it should be realized that inflammatory conditions
caused by innate and adaptive immune responses contribute to,
or may even underlie alterations in vasculature, kidney, and the
regulating sympathetic nervous system, which together cause
hypertension (32).
It is believed that the underlying presence of OSA facilitates
susceptibility to SARS-CoV-2 infection, and increases the risk
for severe COVID-19 and the overall mortality of the disease
(33). The CORONADO study shows that treated OSA is
independently associated with risk of death by day 7 (34).
Research suggests that when controlling for obesity, the presence
of OSA is associated with decreased lung function, decreased
lung-transfer factor for carbon monoxide, and, importantly,
increased lung inflammation (35). Obesity plays a pivotal role
in the pathogenesis of OSA and weight loss of approximately 7–
11% leads to clinically significant and meaningful improvement
of OSA (36). Lifestyle modification with reduced calorie intake
and increased physical activity forms the foundation of all weight
loss interventions and seems to have weight-independent benefits
in OSA (36). Below we discuss the potential benefits of lifestyle
adaptations in light of COVID-19 and its underlying risk factors.
THE INFLUENCE OF LIFESTYLE FACTORS
ON THE IMMUNE SYSTEM
When discussing the relation between obesity and the severity
of COVID-19, it is important to emphasize that obesity is a
complex disease. Next to societal and lifestyle factors, numerous
other factors contribute to weight gain or impair weight loss.
For example, medication may promote weight gain, as well
as endocrine or hypothalamic disease, genetic syndromes or
psychiatric conditions (37). It is counterproductive to blame
people for their obesity or for severe progression of COVID-
19. The obesity stigma is a serious problem in this context, and
guiding people in their attempt to lose weight in a respectful way
is of crucial importance (38, 39). Furthermore, when intensive
lifestyle intervention turns out to be insufficient to lose weight,
other obesity treatments such as pharmacotherapy or bariatric
surgery should be considered to attain a healthier weight (40).
The American Endocrine Society and the European
Association for the Study of Obesity both include lifestyle
interventions, bariatric surgery and pharmacotherapy in
recommended weight reduction strategies for people with
obesity (41, 42). Besides weight reduction effects, bariatric
surgery and pharmacotherapy have also been shown to positively
affect the immune system in obese patients (43–46). The rate of
weight loss for optimal immune system function is yet unclear. It
is known that relatively fast weight reduction through bariatric
surgery as well as more gradual weight loss through lifestyle
modification both improve immune system markers (44, 47). On
the other hand, severe caloric restriction, as well as malnutrition,
reduces immunity and renders one more susceptible for disease
(48, 49). Nevertheless, the negative impact of obesity on general
health and responses to infections, including COVID-19 as
discussed above, warrants vigorous lifestyle intervention (47).
Lifestyle features (nutrition, physical activity, sleep, stress,
alcohol, smoking) interact with genetics to disrupt physiology
and cause disease (50). In this context, a low grade inflammatory
process appears to play a central role in many distinct chronic
non-communicable disorders (51). Since lifestyle is consequently
at the root of these diseases, it follows that lifestyle intervention
should be an integral part of their treatment. Accordingly, a
recent study shows that lifestyle intervention can partly reverse
the pro-inflammatory phenotype associated with obesity (47).
Even though the decline in pro-inflammatory markers was
correlated with a decline of waist circumference and markers of
metabolic syndrome, metabolic improvement was not required
for immunological recovery. This suggests that lifestyle factors
can directly affect the function of the immune system. Below we
discuss the influence of diet, physical activity, stress, smoking,
alcohol and sleep on the immune system as depicted in Figure 2.
Diet
In affluent countries, chronic overeating of diets comprising a
high proportion of ultra-processed energy-dense and nutrient-
poor foods and drinks induces systemic low-grade inflammation,
also referred to as “metaflammation” (52). These Western diet-
components are thought to induce so-called “trained innate
immunity,” i.e., the functional reprogramming of innate immune
cells by exogenous or endogenous stimuli. Training leads to a
more vigorous response toward a second activating challenge,
and this condition may be retained for a long period. This innate
memory gives rise to an elevated inflammatory set point of
innate immune cells, which is mediated through alterations in
their progenitor cells (53). Exposure to adverse metabolic stimuli
induces epigenetic changes during early development of these
immature innate immune cells, which facilitate the expression of
inflammatory genes. The mechanisms explaining inappropriate
adaptive immune activation against pathogens in the presence
of enhanced innate-driven inflammation are far from clear at
present. They might include immune suppression by activated
myeloid cells or regulatory T- and B-cells as well as inappropriate
skewing of adaptive responses (54).
The enhanced inflammatory set point in obesity is reminiscent
of changes occurring during aging, which is also characterized
by increase of inflammatory parameters and designated as
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FIGURE 2 | Positive and negative lifestyle factors influence obesity and the immune system. The negative lifestyle factors (red) can lead to a disbalance in immune
homeostasis, trained innate immunity, inflammaging, and a decrease in infection resistance. Positive factors (green) can protect immune homeostasis and potentially
increase resistance to infection. Trained innate immunity: long term functional reprogramming of innate immune cells, which is evoked by exogenous or endogenous
stimuli and which leads to a usually enhanced response toward a second challenge after return to a non-activated state. Inflammaging: chronic low-grade
inflammation that occurs with aging and is characterized by dysregulated inflammatory responses, in general resulting in increased inflammatory responses and
diminished responses to pathogens like influenza or SARS-CoV-2.
“inflammaging” (55). In fact, alterations in DNA methylation in
blood cells and other tissues can be used as epigenetic marker
of biological age, the ‘epigenetic clock’ (56). Lifestyle-related
risk factors, including obesity and smoking, accelerate epigenetic
aging (55). Moreover, obesity may promote thymic involution,
leading to diminished output of naïve T-lymphocytes, which
accelerates immunosenescence (57).
Dampening inflammation by adequate intake of fruit and
vegetables is essential for prevention of chronic metabolic
diseases, and sufficient consumption thereof is reflected by
inhibition of epigenetic aging (55). Many fruits and vegetables,
e.g., tomatoes, garlic, berries, apples, broccoli, grapes and olives,
have anti-inflammatory effects (58). A number of vitamins (A,
B6, B12, folate, C, D, and E) and trace elements (zinc, copper,
selenium, iron) have been demonstrated to play important
and complementary roles in supporting both the innate and
adaptive immune systems (59). Foods such as nuts, meat, eggs,
shellfish, and wholegrains are good sources of many of these
trace elements. In addition, omega-3 fatty acids derived from
fatty fish have anti-inflammatory action (59). There is evidence
that omega-3 fatty acids can control the cytokine storm in
acute respiratory distress syndrome (ARDS) (60). Such a diet is
consistent with current healthy eating guidelines (60).
Foods containing probiotic and prebiotic substances can
maintain a healthy microbiota, which can also benefit the
immune system (60). The gutmicrobiota plays a role in educating
and regulating the immune system. Gut dysbiosis is a feature of
obesity, chronic disease and many infectious diseases, and has
been described in COVID-19. Dietary approaches to achieve a
healthy microbiota can also benefit the immune system. Indeed,
optimal nutrient intake promotes optimal immune function and
may limit the impact of novel, more virulent pathogenic viruses
(59). It must be emphasized that severe caloric restriction, as
well as malnutrition, reduces immunity and renders one more
susceptible for disease (48, 49). Extreme and prolonged reduction
of caloric intake or crash diets are therefore strongly discouraged.
Experimental evidence of the effects of diet in relation to
COVID-19 is still lacking. However, it is generally accepted
that a diet rich in vegetables, fruit, nuts, legumes, fish, and
‘healthy’ dietary fats is associated with a lower risk of chronic
non-communicable diseases as well as improved immune
function (61). A range of nutrients or bioactive compounds
has been proposed to explain this association. Examples
are polyphenols, vitamin D, n-3 PUFA in autoimmune and
inflammatory disorders, and vitamin D, vitamin E, zinc, and
probiotics in reduction of infection (62). A balanced whole
foods version of a vegetarian or Mediterranean diet fits this
description. Conversely, a diet that is rich in energy-dense,
nutrient-poor foods (i.e., consisting of ultra-processed foods
with high levels of refined carbohydrates, added sugar and fats)
is related to an increased risk of non-communicable diseases
and impaired immune function (63). Moreover, a recent study
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found that ultra-processed food stimulated additional intake of
approximately 500 kcal/day when compared to content-matched
unprocessed diet (64).
Physical Activity
Similar to theWestern diet, a sedentary lifestyle is associated with
abdominal adiposity, a pro-inflammatory state and increased
risk of infection (65). Besides facilitating weight loss, regular
physical activity decreases the activation of the immune system
and improves immunosurveillance and immunocompetence
(65). Regular exercise may limit or delay inflammaging (66).
Subsequently, a physically active lifestyle reduces the risk of
contracting a range of communicable diseases including viral and
bacterial infections (65, 66).
The near-daily practice of moderate intensity exercise (e.g.,
walking or cycling) reduces upper respiratory tract infection
symptom days by 40–50% (67). There is a dose-response
relationship between the intensity of regular exercise and the
risk for infection (65). Exercise intensity is commonly expressed
as the Metabolic Equivalent of Task (MET) which is the ratio
of a person’s working metabolic rate relatively to their resting
metabolic rate. Light to moderate exercise (MET 2–5.9, e.g.,
walking, vacuum cleaning or yoga) is better than inactivity (MET
<2, e.g., writing or desk work) but vigorous exercise (MET 6–
8.7, e.g., running, basketball or swimming) is even better. On
similar note, short periods of maximum intensity training (High-
intensity interval training or HIIT) seem to be a valuable addition
to moderate-intensity continuous training in terms of enhancing
cardiorespiratory fitness, metabolic hemostasis, vascular function
and immune system function (68, 69). However, prolonged and
intensive or (near) maximal intensity exercise is associated with
an increased illness risk (67).
Substantial reduction in acute respiratory infection illness is
detectable as soon as after 8 weeks of moderate intensity exercise
(70). Most studies used a moderate intensity program of 30–45
min/day for 5 days/ week (67). This is in line with the Global
recommendations on Physical Activity for Health on which most
national guidelines are based (71). Thus, adoption of a physically
active lifestyle by a substantial percentage of the population
would probably curtail infectious pandemics such as COVID-19
and non-infectious pandemics such as obesity (65).
Stress
Different emotional states, or exposure to psychological stressors,
are associated with enhanced susceptibility to, or increased
severity of disease through nervous system-induced alterations
in innate and adaptive immunity (72). A main component of
the stress response is cortisol, which production and secretion
are regulated by the hypothalamus-pituitary-adrenal axis (73).
Cortisol has many functions in the human body, such as
mediating the stress response, and regulating metabolism as
well as, inflammatory-, and immune function (73). Cortisol is
ordinarily anti-inflammatory and confines the immune response,
but chronic hypercortisolemia can lead to resistance of the
immune system. The accumulation of stress hormones gives
rise to an increased production of inflammatory cytokines
that compromises the immune response (74). It has been
demonstrated that individuals reporting higher levels of stress
aremore likely to develop clinical symptoms during experimental
respiratory viral infection (72). Behavioral interventions targeted
at alleviating stress, promoting heightened states of relaxation
and encouraging moderate physical activity have been shown
to bolster anti-viral immune responses and decrease markers of
inflammation (75). A meta-analysis focusing on psychological
interventions to alleviate stress showed positive effects on the
immune system. It even suggested a positive relation between
the frequency of self-reported of stress-reducing practice and a
more adequate functioning of the immune system (76). Besides
the impact on inflammatory markers, stress also promotes other
negative lifestyle factors such as unhealthy eating and poor
sleeping quality (77).
Smoking
Nicotine and other tobacco components have several pro- as well
as anti-inflammatory effects, and thus contribute to an altered
immune set point in smokers (78). Current or former smoking
is a risk factor for severe disease in patients with COVID-19.
Smokers appear to have a 40% higher chance of developing severe
symptoms, and a 140% higher chance of being admitted to an
ICU, need mechanical ventilation or die as compared to non-
smokers (79). A similar observation was made in patients with
influenza (80). Smokers were over 5 times more likely to develop
laboratory-confirmed influenza, and 34% more likely to develop
influenza-like illness than non-smokers. Importantly, smoking
cessation recovers airway ciliary clearance and immune function
as early as 1 month after the intervention (81). Thus, smoking
cessation is strongly encouraged as a public health measure to
limit the global impact of COVID-19 (81).
Alcohol
Alcohol consumption affects the number, survival and function
of both innate and adaptive immune cells, thereby interfering
with immune responses (82). Consumption of high doses can
directly suppress a wide range of immune responses, and alcohol
abuse is associated with an increased incidence of infectious
disease (83). For instance, alcoholics are highly susceptible to
respiratory pathogens and lung injury, and have a 2–4 fold
increased risk of ARDS (84). Furthermore, alcohol consumption
increases the risk of community-acquired pneumonia in adults
(85). A dose-response relationship is observed, indicating that
the risk for pneumonia increases by 8% for every 10–20 g (one
unit of alcohol) higher daily alcohol intake. Surprisingly, even
a single episode of binge drinking can have measurable effects
on the immune system, inducing a transient pro-inflammatory
state within the first 20min after alcohol ingestion, followed by an
anti-inflammatory state 2–5 h after alcohol ingestion (82). Also in
animal models of pulmonary infections, alcohol administration
is associated with adverse clinical parameters and increased
lung damage (82). In many cultures, drinking alcohol is socially
accepted and integrated in daily life. Increased awareness of the
negative effects of alcohol and making moderation or abstinence
the default choice are of paramount importance for public health.
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Sleep
It is suggested that both circadian rhythm and sleep significantly
modify the susceptibility to SARS-CoV-2 infection as well as
the overall clinical manifestations of COVID-19 (86). This
relates to an interdependent balance maintained between the
circadian clock, the intestinal microbiota and immune system
activity (87). Naturally occurring sleep acutely enhances the
expression of cytokines such as IL-12 and IFN-γ that regulate
anti-viral immune defense mechanisms (88). Also, sleep might
improve immunological memory formation by boosting the
number of antigen presenting cells and CD4+ T-cells (89). The
central nervous system seems to use the metabolically quiescent
period of sleep to regulate both innate and antiviral immune
responses (88). Sleep deprivation leads to decreased lymphocyte
blastogenesis and natural killer cell activity, and upregulates IL-1
and IL-2 (90). However, sleep also increases IL-2 production by
T-cells (88). Short habitual sleep (<6 h) is associated in humans
with reduced life span, increased vulnerability to viral infection
and reduced antibody titers after vaccination (91). In addition,
short-term sleep deprivation prior to vaccination appears to
negatively impact antibody titers after influenza vaccination
(92). In rodents, sleep disturbances reduces influenza vaccine
efficacy (93). When attempting to improve on sleep quality to
boost the immune system, paucity of evidence prevents strong
recommendations. However, a key point is that in current times
circadian rhythm and sleep disruption frequently occur through
shift work, nighttime light exposure and social jet lag (91).
Morin et al. provide a condense overview of recommendations to
improve sleep quality, especially during the COVID-19 pandemic
(Table 2) (94). Further research could explore the effects of these




Thus, we know that obesity, chronic disease and their
underlying causes impair immune function and leave individuals
more vulnerable to infection. These underlying causes include
behavioral and modifiable factors such as an unhealthy diet,
inadequate physical activity, chronic stress, use of alcohol and
tobacco and suboptimal sleep quality (Table 3). To improve on all
these aspects of health, multiple methods can be used.Wemake a
case for health education, choice architecture, and regulation on
local, national, and international levels.
Undeniably, widespread health education is an important
aspect of reaching these lifestyle goals. This challenge is a
shared responsibility of healthcare professionals, governments,
the private sector, and civil society. Healthcare organizations and
professionals should advocate the use of lifestyle as therapy in its
own right, of equal importance to medication and interventions.
Lifestyle modification should be an integral part of chronic
disease management. National and local policies should address
social determinants of health and health inequalities (95).
Extra attention should be given to personal health and lifestyle
factors in periods of complete or partial lockdown. Lockdown
TABLE 2 | Strategies to manage sleep disturbances during the COVID-19
pandemic.
1. Make sleep a priority and reserve at least 7–8 h per night for sleep.
2. Keep a regular schedule for sleep, meals, work, and social contacts. These
activities are important time cues that help maintain entrainment of one’s
biological clock.
3. Get as much daylight exposure as possible (turn on the lights, open the
curtains, go outside if possible) to regulate sleep-wake and circadian rhythms.
4. Avoid using electronics (cellular, tablets) in the bed or bedroom or
near bedtime.
5. Allow at least 1 h to unwind before bedtime.
6. If sleep does not come within 15–20min, go to another room and engage in
quiet activities (reading), and return to bed only when sleep is imminent.
7. Reserve the bed and bedroom for sleep and sex only. This is not the place to
worry, problem-solve, or plan the next day.
8. Get up at the same time every morning, regardless of the amount of sleep.
While it may be tempting to sleep in, particularly when there is no obligation to
be at work, it is best to arise at the same time to keep a regular
sleep-wake schedule.
9. Although it is better to avoid napping for someone with insomnia, napping is
beneficial for sleep-deprived people. Older adults, without sleep problems,
may also benefit from a short catnap (15–20min) around mid-day.
10. Keep in mind that short bouts of insomnia is a normal reaction to stressful life
events, but when sleep difficulties occur several nights per week, take action
and seek professional help to prevent acute insomnia from turning into
chronic insomnia.
Adopted from Morin et al. (94).
TABLE 3 | Aspects of lifestyle to be addressed to improve immune function.
Diet • Increase the intake of healthy foods (e.g., vegetables,
fruits, nuts, legumes, whole grains, and fish)
• Decrease the intake of unhealthy foods and drinks
(e.g., ultra-processed, refined carbohydrates, added
sugars, and fats)
Physical activity • Increase adherence to (inter)national physical
activity guidelines
• Decrease sedentary behavior
Stress • Increase active relaxation
• Decrease chronic stress (e.g., in studies, jobs, and
social life)
• Increase skills and opportunities to cope with
chronic stress
Smoking and alcohol • Decrease the marketing, sale and use of (legal)
addictive substances such as tobacco and alcohol
• Provide help for those addicted
Sleep • Increase sleeping quality
periods lead to increases in sedentary behavior (unhealthy)
food consumption, alcohol consumption, tobacco use, stress,
and decreased well-being (96–98). Distressingly, increased food
consumption and snacking are more prevalent in people with
overweight or obesity. Even 2 weeks of physical inactivity and
a positive energy balance can lead to reduced insulin sensitivity,
higher total body fat, and a proinflammatory state (99). People
should be aware of the influence of lockdown on their daily
habits and be guided to eat healthy, exercise adequately, and find
help for psychosocial adversities. We conclude that advocating
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TABLE 4 | Facets of the campaign for healthier lifestyles.
Health education • Public
• Healthcare professionals
• Policy makers
• Extra attention during lockdown
Environment • Supermarkets, Schools, Workplaces
◦ Food positioning (106)
• Built environment
◦ Physical activity and active transport (108)
Regulation • Taxation, pricing, ban, and restriction of advertising and
sponsorship (109)
home-confinement should be accompanied by stressing the need
to maintain a healthy lifestyle.
Besides health education, we need to realize that our
environment influences our choices substantially. Choices are
made by means of two cognitive processes: the reflective and
the impulsive system. The former is rational and conscious,
the latter is quick, automatic, and subconscious (100). In the
context of the current environment, we make approximately 219
decisions in regard to food per day, of which 90% subconsciously
(101). Default options such as easy availability of unhealthy
foods significantly influence our choices in a negative way (102).
Thus, in order to promote healthy choices we need to create an
environment in which the default option is a healthy option.
In many parts of the world people currently live in
an obesogenic environment (103). In recent decades most
societies increasingly offer an overabundance of cheap and
convenient energy-dense and nutrient-poor foods and drinks,
which contribute to adverse dietary choices. Intensive marketing
of ultra-processed foods only makes matters worse. Moreover,
many of the current environments promote sedentary behavior
and discourage physical activity (104). As a society, we need to
promote a healthy lifestyle, and thereby decrease rates of obesity
and improve immune function. To do so, we need to reconstruct
our living environment so as to facilitate and promote healthy
dietary choices, physical activity, stress relieve, and regular sleep
(105). Changing choice architecture can be done by changing
food positioning in supermarkets, schools, or workplaces (106,
107). Another example is using built environment to increase
physical activity and active transport (108).
In addition to choice architecture, creating healthy
communities requires regulation by governments aimed at
protecting society from the commercial determinants of chronic
non-communicable diseases (109). This includes regulating
the sale and promotion of unhealthy commodities such as
tobacco, alcohol, and ultra-processed food and drinks (109).
Strong leadership is essential to resist attempts by powerful
organizations with vested interests (e.g., the tobacco, food,
and alcohol industries) to undermine the development and
implementation of effective policies and laws (110). Evidence-
based approaches such as legislation, regulation, taxation,
pricing, ban, and restriction of advertising and sponsorship
should be introduced to reduce consumption of unhealthy
commodities (109). All in all, the campaign for healthier lifestyle
includes, but is not limited to, aspects on health education,
environmental changes, and regulatory actions (Table 4).
CONCLUSIONS
COVID-19 has significant impact on public health. Obesity,
chronic disease, and various lifestyle components increase the
severity of the disease course, the appeal to health care, and the
mortality rate of SARS-CoV-2 infections. The harmful impact of
these factors on the immune system probably explains the worse
outcome to a large extent. Conditions associated with low-grade
systemic inflammation, such as obesity, metabolic syndrome,
and old age, hamper an optimal and timely response by the
immune system to an infectious challenge like SARS-CoV-2.
Several Western diet components train innate immune cells so as
to adopt a more pro-inflammatory set point, which enigmatically
diminishes their capacity to activate adequate adaptive immunity
required for an effective battle against pathogens.
Adapting lifestyle on a global scale can most likely enhance
population resistance to viral and other infections. However,
making healthy choices is not as easy as knowing what to choose.
In this context it is important to be aware of the existing obesity
stigma and to counteract it. Obesity and related cardiometabolic
diseases are not only a problem of the individual, but a burden for
society as well. These metabolic disorders are primarily caused
by environmental and societal factors, in concert with genetic
and other individual (biological) characteristics. Reconstruction
of our living environment so as to promote healthier lifestyles
is of paramount importance to both prevent and treat obesity
and related disorders. Obviously, a collective effort is required to
get this done. Healthcare institutions, governments, the private
sector, and (creative) citizens have to put their heads together to
map out the route to a healthy future. Together we can change
our lifestyle-choice architecture to make healthy living the norm,
and thereby improve immune function to be better prepared for
the next viral pandemic.
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